longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Bio-Rad Lab

BIO

376.4101.57% ( -6.000 )
Closed: Sep 18, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 45.25, above the reasonable range, cheaper than 4.98% of the time in the past 5 years, and the industry ranks 16/59, the industry Median -1.52.

45.25xP/E
$376.41Stock price
$8.32Earnings per share
45.25xP/E
Stock price$376.41Earnings per share$8.32

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-6.98x
Typical range
-26.01x–4.15x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
ILMNUSIllumina
43.91x9.25%$36.18B
WSTUSWest Pharmaceutical
45.14x26.29%$25.50B
BIOUSBio-Rad Lab
45.25x70.13%$10.06B
BIOBBio-Rad Lab-B
43.89x--$9.76B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.